Prostate Cancer - Results from #19540

Results of a cohort of 200 hormone-naïve consecutive patients with prostate cancer treated with iodine 125 permanent interstitial brachytherapy by the same multidisciplinary team - Abstract November 26, 2014

Integrated analysis of epigenomic and genomic changes by DNA methylation dependent mechanisms provides potential novel biomarkers for prostate cancer - Abstract November 26, 2014

Meta-analysis of nonsteroidal anti-inflammatory drug intake and prostate cancer risk - Abstract November 26, 2014

Docetaxel-based therapy with and without antiangiogenic agents as first-line chemotherapy for castration-resistant prostate cancer: A meta-analysis of nine randomized controlled trials - Abstract November 26, 2014

Upgrading and upstaging in prostate cancer: From prostate biopsy to radical prostatectomy - Abstract November 26, 2014

Focal therapy: Patients, interventions, and outcomes-A report from a consensus meeting - Abstract November 26, 2014

Prevention and early detection of prostate cancer - Abstract November 26, 2014

Quantifying the effect of seed orientation in postplanning dosimetry of low-dose-rate prostate brachytherapy - Abstract November 25, 2014

Coverage-based treatment planning to accommodate deformable organ variations in prostate cancer treatment - Abstract November 25, 2014

Variability in date of prostate cancer diagnosis: A comparison of cancer registry, pathology report, and electronic health data sources - Abstract November 25, 2014

Biopsy sampling and histopathological markers for diagnosis of prostate cancer - Abstract November 24, 2014

Sexual partners, sexually transmitted infections, and prostate cancer risk - Abstract November 24, 2014

The impact of numeracy on verbatim knowledge of the longitudinal risk for prostate cancer recurrence following radiation therapy - Abstract November 24, 2014

Prostate specific antigen. Current clinical application and future prospects - Abstract November 24, 2014

The use of early postoperative prostate-specific antigen to stratify risk in patients with positive surgical margins after radical prostatectomy - Abstract November 24, 2014

Prognostic factors for survival in noncastrate metastatic prostate cancer: Validation of the Glass model and development of a novel simplified prognostic model - Abstract November 24, 2014

From bench to bedside: Immunotherapy for prostate cancer - Abstract November 24, 2014

Impact of enzalutamide on quality of life in men with metastatic castration-resistant prostate cancer after chemotherapy: Additional analyses from the AFFIRM randomized clinical trial - Abstract November 24, 2014

Family history in the Finnish Prostate Cancer Screening Trial - Abstract November 21, 2014

Robot-assisted radical prostatectomy: Multiparametric MR imaging-directed intraoperative frozen-section analysis to reduce the rate of positive surgical margins - Abstract November 21, 2014

Page 978 of 1447